Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shengpeng Zhong
Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer
International Journal of Oncology
Cancer Research
Oncology
Related publications
FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Acquired Differential Regulation of Caspase-8 in Cisplatin-Resistant Non-Small-Cell Lung Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
miRNA‑328 Overexpression Confers Cisplatin Resistance in Non‑small Cell Lung Cancer via Targeting of PTEN
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells
Oncotarget
Oncology
Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas
FOXF1 Mediates Mesenchymal Stem Cell Fusion-Induced Reprogramming of Lung Cancer Cells
Oncotarget
Oncology
Non-Small Cell Lung Cancer
Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.
Thorax
Pulmonary
Respiratory Medicine